State DC
Clinical Trials in Washington D.C.
Recruiting clinical trials with at least one study location in Washington D.C.. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington D.C.
Malignant Solid Neoplasm (5)Alzheimer Disease (4)Prostate Cancer (3)Solid Tumor (3)Ewing Sarcoma (3)Hepatocellular Carcinoma (3)Myeloproliferative Neoplasm (2)Acute Treatment of Migraine (2)Asthma in Children (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Acute Myeloid Leukemia (2)
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06049888 N/A
Recruiting
Does Social Media Impact Adolescent Mental Health?
Condition
Mental Health
Enrollment
500 pts
Location
United States
Sponsor
Georgetown University
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07011173 EARLY_Phase 1
Recruiting
Assistance Delivery and Muscle Coordination
Condition
Stroke
Enrollment
30 pts
Location
United States
Sponsor
The Catholic University of Ame
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
NCT04910269 Phase 3
Recruiting
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Condition
COVID
Enrollment
820 pts
Location
United States, Argentina, Australia
Sponsor
University of Minnesota
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Child...
Condition
Acute Biphenotypic Leukemia
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatm...
Condition
Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC
NCT01193075 N/A
Recruiting
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT...
Condition
Charcot Marie Tooth Disease
Enrollment
5,000 pts
Location
United States, Australia, Canada
Sponsor
Michael Shy
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07195695 Phase 3
Recruiting
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically...
Condition
Non-small Cell Lung Cancer
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05966467 N/A
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapie...
Condition
Neuromyelitis Optica Spectrum Disorder
Enrollment
122 pts
Location
United States, Argentina, Canada
Sponsor
Alexion Pharmaceuticals, Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06623981 N/A
Recruiting
The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clin...
Condition
Asthma in Children
Enrollment
60 pts
Location
United States
Sponsor
Children's National Research I
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT03474029 Phase 2, Phase 3
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given D...
Condition
Latent Tuberculosis
Enrollment
3,400 pts
Location
United States, Australia, Canada
Sponsor
Centers for Disease Control an
NCT06501781 N/A
Recruiting
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes...
Condition
HIV Infections
Enrollment
186 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI